CNTX Archived Articles
Context Therapeutics Inc. (CNTX): Building a Formidable Pipeline of T-Cell Engaging Bispecific Antibodies
Published on March 16, 2025
Context Therapeutics Inc. (NASDAQ:CNTX): Pioneering the Future of Solid Tumor Treatments
Published on November 30, 2024
CNTX: Promising Bispecific Antibody Candidate Poised for Clinical Advancement
Published on September 24, 2024